MJardin to Present at Canaccord Genuity 2nd Annual U.S. Cannabis Symposium
03 10월 2019 - 4:06AM
MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR)
(OTCQX: MJARF), a leader in premium cannabis production, announced
today that the Company will present at the Canaccord Genuity 2nd
Annual U.S. Cannabis Symposium.
Patrick Witcher, Chief Operating Officer, will present on the
Company’s growth strategy and will be joined by Board member and
Company Founder, James Lowe, to meet with investors. The formal
presentation is scheduled for 11:50 am ET on Thursday, October 3rd,
2019 at the Sheraton Centre Toronto Hotel and can be found on the
Company’s website at
http://investors.mjardin.com/Investor-Presentations.
This one-day event will feature company presentations and
meetings with senior management teams across the U.S. cannabis
industry supply chain, including multi-state operators, technology
providers, brand owners, hemp producers, oil extractors and
ancillary products businesses.
About MJardin GroupMJardin is a cannabis
management platform with extensive experience in cultivation,
processing, distribution and retail. For over 10 years, MJardin has
refined cultivation methodologies, developed state of the art
facilities and implemented vertical integration for and on behalf
of license owners. MJardin is based in Denver, Colorado and
Toronto, Canada. For more information, please visit
www.mjardin.com.
The CSE has not in any way passed upon the merits of and has
neither approved nor disapproved the contents of this news
release. This news release does not constitute an offer to
sell or a solicitation of an offer to sell any of the securities in
the United States. The securities have not been and will not be
registered under the United States Securities Act of 1933, as
amended (the “U.S. Securities Act”) or any state securities laws
and may not be offered or sold within the United States or to U.S.
Persons unless registered under the U.S. Securities Act and
applicable state securities laws or an exemption from such
registration is available.
Forward-Looking InformationThis news release
contains forward-looking information based on current expectations.
Statements about, among other things, future developments and the
business and operations of MJardin, our production capacity, our
production results, trading of MJardin’s shares on the OTCQX Best
Market, the receipt of any pending regulatory approvals or
licenses, the growth of our global footprint and our intentions to
leverage our scale for continued organic growth and to pursue
strategic investments are all forward-looking information. These
statements should not be read as guarantees of future performance
or results. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results,
performance or achievements to be materially different from those
implied by such statements. Such factors include, but are not
limited to: our ability to identify and pursue growth, financing
and other strategic objectives, and the regulatory and economic
environments in the jurisdictions we operate or intend to operate
or investment in. Although such statements are based on
management’s reasonable assumptions at the date such statements are
made, there can be no assurance that the proposed acquisition will
occur and that such forward-looking information will prove to be
accurate, as actual results and future events could differ
materially from those anticipated in such forward-looking
information. Accordingly, readers should not place undue reliance
on the forward-looking information. MJardin assumes no
responsibility to update or revise forward-looking information to
reflect new events or circumstances unless required by applicable
law.
INVESTOR CONTACT:
INVESTOR CONTACT: Ali Mahdavi Capital Markets & Investor
Relations416-962-3300 Ali.mahdavi@MJardin.com |
Pat Witcher Chief Operating Officer
720.613.4019Pat.Witcher@Mjardin.com |
MJardin (CSE:MJAR)
과거 데이터 주식 차트
부터 2월(2) 2025 으로 3월(3) 2025
MJardin (CSE:MJAR)
과거 데이터 주식 차트
부터 3월(3) 2024 으로 3월(3) 2025